Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 13/20 | 0.83 |
| ▸ | MMP9 | P14780 | 13/20 | 0.83 |
| ▸ | MMP13 | P45452 | 13/20 | 0.83 |
| ▸ | ADAM17 | P78536 | 13/20 | 0.83 |
| ▸ | MMP8 | P22894 | 7/20 | 0.54 |
| ▸ | MMP3 | P08254 | 4/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7423746 | 0.91 | MMP1 (0.82) | MMP1MMP9MMP13ADAM17MMP8 | |
| SCHEMBL6612778 | 0.89 | MMP1 (0.82) | MMP1MMP9MMP13ADAM17MMP3 | |
| SCHEMBL7420443 | 0.88 | MMP1 (0.83) | MMP1MMP9MMP13ADAM17MMP8 | |
| SCHEMBL3947850 | 0.83 | MMP13 (0.68) | MMP1MMP9MMP13ADAM17 | |
| SCHEMBL3940171 | 0.82 | MMP13 (0.65) | MMP1MMP9MMP13ADAM17 | |
| SCHEMBL7569364 | 0.81 | MMP1 (0.83) | MMP1MMP9MMP13ADAM17MMP8 | |
| SCHEMBL6610602 | 0.81 | MMP1 (0.84) | MMP1MMP9MMP13ADAM17MMP3 | |
| SCHEMBL7427908 | 0.79 | MMP1 (0.81) | MMP1MMP9MMP13ADAM17MMP8 | |
| SCHEMBL6614483 | 0.79 | MMP1 (0.62) | MMP1MMP9MMP13ADAM17 | |
| SCHEMBL6608196 | 0.79 | MMP1 (0.62) | MMP1MMP9MMP13ADAM17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1051407-A1 | 2,3,4,5-TETRAHYDRO-1H-[1,4]-BENZODIAZEPINE-3-HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | American Cyanamid Company (US) | 2000-11-15 | — | — | EP | claimed |
| US-6071903-A | ENZYME INHIBITORS OF MATRIX METALLOPROTEINASES (MMPS); ANTITUMOR,-CARCINOGENIC AND -ARTHRITIC AGENTS; OSTEOARTHRITIS; RHEUMATOID DISEASES; DEGENERATIVE CARTILAGE LOSS; LONG-ACTING, ORALLY BIOAVAILABLE NONPEPTIDE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-06-06 | — | — | US | claimed |
| WO-1999037625-A1 | 2,3,4,5-TETRAHYDRO-1H-[1,4]-BENZODIAZEPINE-3-HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1999-07-29 | — | — | WO | claimed |
| EP-1051407-A1 | 2,3,4,5-TETRAHYDRO-1H-[1,4]-BENZODIAZEPINE-3-HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | American Cyanamid Company (US) | 2000-11-15 | — | — | EP | disclosed |
| US-6071903-A | ENZYME INHIBITORS OF MATRIX METALLOPROTEINASES (MMPS); ANTITUMOR,-CARCINOGENIC AND -ARTHRITIC AGENTS; OSTEOARTHRITIS; RHEUMATOID DISEASES; DEGENERATIVE CARTILAGE LOSS; LONG-ACTING, ORALLY BIOAVAILABLE NONPEPTIDE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-06-06 | — | — | US | disclosed |
| WO-1999037625-A1 | 2,3,4,5-TETRAHYDRO-1H-[1,4]-BENZODIAZEPINE-3-HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1999-07-29 | — | — | WO | disclosed |